Cargando…
Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
In the present study, a highly stable luteinizing-hormone-releasing hormone (LHRH)-conjugated PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were developed for the successful treatment of prostate cancers. We have demonstrated that a unique combination of targeted drug delivery and con...
Autores principales: | Cao, Long-Bin, Zeng, Sha, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916070/ https://www.ncbi.nlm.nih.gov/pubmed/27325521 http://dx.doi.org/10.1186/s11671-016-1509-3 |
Ejemplares similares
-
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010) -
Biodegradable nanoparticles of methoxy poly(ethylene glycol)-b-poly( d, l-lactide)/methoxy poly(ethylene glycol)- b-poly(ϵ-caprolactone) blends for drug delivery
por: Baimark, Yodthong, et al.
Publicado: (2012) -
Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
por: Lio, Daniel, et al.
Publicado: (2016) -
Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery
por: Wu, Zhi Min, et al.
Publicado: (2012) -
Preparation and Evaluation of Poly(Ethylene Glycol)–Poly(Lactide) Micelles as Nanocarriers for Oral Delivery of Cyclosporine A
por: Zhang, Yanhui, et al.
Publicado: (2010)